(Q41978254)

14 October 2017

Focal cerebral ischemia in the cat: pretreatment with a competitive NMDA receptor antagonist, D-CPP-ene (English)

1 reference

14 October 2017

1 reference

Bullock R

1

1 reference

14 October 2017

Graham DI

2

1 reference

14 October 2017

Chen MH

3

1 reference

14 October 2017

Lowe D

4

1 reference

14 October 2017

McCulloch J

5

1 reference

14 October 2017

1 September 1990

1 reference

Journal of Cerebral Blood Flow & Metabolism

14 October 2017

1 reference

14 October 2017

10

1 reference

14 October 2017

668-674

1 reference

14 October 2017

5

1 reference

Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis

14 October 2017

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1990.120

7 January 2021

Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1990.120

7 January 2021

The N-methyl-D-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbils

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1990.120

7 January 2021

Ifenprodil and SL 82.0715 are antagonists at the polyamine site of the N-methyl-D-aspartate (NMDA) receptor

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1990.120

7 January 2021

Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1990.120

7 January 2021

Neurobiology. Taking apart NMDA receptors

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1990.120

7 January 2021

The competitive N-methyl-D-aspartate (NMDA) antagonist CGS 19755 attenuates the rate-decreasing effects of NMDA in rhesus monkeys without producing ketamine-like discriminative stimulus effects.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1990.120

7 January 2021

Direct evidence that excitotoxicity in cultured neurons is mediated via N-methyl-D-aspartate (NMDA) as well as non-NMDA receptors

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1990.120

7 January 2021

Kynurenate inhibition of cell excitation decreases stroke size and deficits

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1990.120

7 January 2021

7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1990.120

7 January 2021

Effects of MK-801 upon local cerebral glucose utilisation in conscious rats and in rats anaesthetised with halothane.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1990.120

7 January 2021

Effects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1990.120

7 January 2021

Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1990.120

7 January 2021

Differential effects of competitive and non-competitive N-methyl-D-aspartate antagonists on glucose use in the limbic system

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1990.120

7 January 2021

The effects of N-methyl-D-aspartate receptor blockade with MK-801 upon the relationship between cerebral blood flow and glucose utilisation.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1990.120

7 January 2021

Protective effect of the glutamate antagonist, MK-801 in focal cerebral ischemia in the cat.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1990.120

7 January 2021

Focal cerebral ischaemia in the cat: treatment with the glutamate antagonist MK-801 after induction of ischaemia

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1990.120

7 January 2021

The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1990.120

7 January 2021

Effect of the NMDA antagonist MK-801 on local cerebral blood flow in focal cerebral ischaemia in the rat

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1990.120

7 January 2021

An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1990.120

7 January 2021

Glutamate and the pathophysiology of hypoxic--ischemic brain damage

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1990.120

7 January 2021

Phencyclidine reduces postischemic neuronal necrosis in rat hippocampus without changing blood flow

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1990.120

7 January 2021

Blockade of N -Methyl-D-Aspartate Receptors May Protect Against Ischemic Damage in the Brain

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1990.120

7 January 2021

The novel anticonvulsant MK-801: a potent and specific ligand of the brain phencyclidine/sigma-receptor.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1990.120

7 January 2021

Dextromethorphan protects against cerebral injury following transient focal ischemia in rabbits

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1990.120

7 January 2021

Long-term development of selective neuronal loss and the mechanism of protection by 2-amino-7-phosphonoheptanoate in a rat model of incomplete forebrain ischaemia.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1990.120

7 January 2021

Alterations in local cerebral glucose utilization induced by phencyclidine.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1990.120

7 January 2021

Hypoglycemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1990.120

7 January 2021

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1990.120

7 January 2021

Identifiers

DOI

10.1038/JCBFM.1990.120

1 reference

14 October 2017

1 reference